Latest News and Press Releases

Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher”), a company specializing in the development of Internet of Things (IoT) and...

Peripheral Artery Disease Device Manufacturer Targeted for Joint Venture HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...

LOS ANGELES, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - Right On Brands, Inc.™ (OTCQB: RTON.) today has announced that it's ENDO labs subsidiary has developed and produced a topical based...

VERNON, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf” or the "Company") (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA), a plant-forward wellness brand...

TSX-Venture Exchange: SUGR CALGARY, Alberta, Nov. 13, 2018 (GLOBE NEWSWIRE) -- SugarBud Craft Growers Corp. (“SugarBud” or the “Company”) is pleased to announce the execution of an investment...

TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Graph Blockchain Inc. (“Graph” or “Company”) (CSE: GBLC) is very pleased to announce that Bernie Rice has joined the Graph Board of Directors.  With this...

WATERLOO, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Client Outlook Inc. and Mach7 Technologies (Mach7) announced today they have been selected to spearhead Sentara Healthcare’s PACS Modernization...

Odevixibat selected as International Nonproprietary Name (INN) for A4250 A4250 granted Fast Track and additional Orphan Drug designations A4250 Phase 3 trial progressing as planned, new natural...

Two Additional Patients Dosed With SGT-001 Gene Transfer in IGNITE DMD Clinical Trial Company Plans to Report Preliminary Results from IGNITE DMD in the First Quarter of 2019 CAMBRIDGE, Mass., Nov. ...

XMT-1536 Phase 1 Dose Escalation Ongoing with Data Expected in the First Half of 2019 XMT-1522 Phase 1 Dose Escalation Enrollment Resumed Mersana to Present New Data on Dolasynthen and...